Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy
S Zhou, B Yang, Y Xu, A Gu, J Peng, J Fu - Journal of Molecular Modeling, 2022 - Springer
FMS-like tyrosine kinase 3 (FLT3) serves as an important drug target for acute myeloid
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy.
S Zhou, B Yang, Y Xu, A Gu… - Journal of Molecular …, 2022 - search.ebscohost.com
FMS-like tyrosine kinase 3 (FLT3) serves as an important drug target for acute myeloid
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy
S Zhou, B Yang, Y Xu, A Gu… - Journal of molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
FMS-like tyrosine kinase 3 (FLT3) serves as an important drug target for acute myeloid
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy.
S Zhou, B Yang, Y Xu, A Gu, J Peng… - Journal of Molecular …, 2022 - europepmc.org
FMS-like tyrosine kinase 3 (FLT3) serves as an important drug target for acute myeloid
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …
leukemia (AML), and gene mutations of FLT3 have been closely associated with AML …